Mylan, Pfizer Transaction to be Postponed Until Second Half of 2020
Mylan and Pfizer announced a postponement of the transaction that would see Mylan and Upjohn Combined until the second half of the year as a result of the current COVID-19 pandemic.
In a March 26, 2020 press release, Mylan and Pfizer announced a postponement of the transaction that would see Mylan and Upjohn Combined until the second half of the year as a result of the current COVID-19 pandemic.
Although the transaction will be delayed, there will be no other changes to the previously announced terms or plans regarding the transaction. The companies stated that there is continued work on the integration to ensure readiness for a successful close.
Furthermore, as a result of the increasing restrictions, particularly in The Netherlands where Mylan is based, Mylan’s extraordinary general meeting of shareholders has been rescheduled from April 27, 2020 to June 30, 2020 and will be hosted on the same day as the company’s annual general meeting.
Source: Mylan
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.
